Literature DB >> 35852587

ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes.

Emma M Lessieur1, Haitao Liu2,3, Aicha Saadane4, Yunpeng Du4, Jianying Kiser4, Timothy S Kern4,5.   

Abstract

AIMS/HYPOTHESIS: Induction of intercellular adhesion molecule-1 (ICAM-1) has been implicated in the development of macrovascular and microvascular diseases such as diabetic retinopathy. Lesions of diabetic retinopathy are unique to the retina but the reason for this is unclear, as all tissues are exposed to the same hyperglycaemic insult. We tested whether diabetes induces ICAM-1 on the luminal surface of endothelial cells to a greater extent in the retina than in other tissues and the role of vision itself in that induction.
METHODS: Experimental diabetes was induced in C57Bl/6J, P23H opsin mutant and Gnat1-/- × Gnat2-/- double knockout mice using streptozotocin. The relative abundance of ICAM-1 on the luminal surface of endothelial cells in retina and other tissues was determined by conjugating anti-ICAM-1 antibodies to fluorescent microspheres (2 μm), injecting them intravenously and allowing them to circulate for 30 min. After transcardial perfusion, quantification of microspheres adherent to the endothelium in tissues throughout the body was carried out by fluorescent microscopy or flow cytometry. Mice injected with lipopolysaccharide (LPS) were used as positive controls. The difference in leucostasis between retinal and non-retinal vasculature was evaluated.
RESULTS: Diabetes significantly increased ICAM-1-mediated adherence of microspheres to retinal microvessels by almost threefold, independent of sex. In contrast, diabetes had a much smaller effect on endothelial ICAM-1 in other tissues, and more tissues showed a significant induction of endothelial ICAM-1 with LPS than with diabetes. The diabetes-induced increase in endothelial ICAM-1 in retinal vasculature was inhibited by blocking phototransduction in photoreceptor cells. Diabetes significantly increased leucostasis in the retina by threefold compared with a non-ocular tissue (cremaster). CONCLUSIONS/
INTERPRETATION: The diabetes-induced upregulation of ICAM-1 on the luminal surface of the vascular endothelium varies considerably among tissues and is highest in the retina. Induction of ICAM-1 on retinal vascular endothelial cells in diabetes is influenced by vision-related processes in photoreceptor cells. The unique presence of photoreceptors in the retina might contribute to the greater susceptibility of this tissue to vascular disease in diabetes.
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Adhesion molecule; Diabetes; Diabetic retinopathy; ICAM-1; Leucostasis; Photoreceptors; Phototransduction; Vascular inflammation

Mesh:

Substances:

Year:  2022        PMID: 35852587      PMCID: PMC9481679          DOI: 10.1007/s00125-022-05719-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.460


  48 in total

Review 1.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

2.  Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study.

Authors:  K Furuya; H Takeda; S Azhar; R M McCarron; Y Chen; C A Ruetzler; K M Wolcott; T J DeGraba; R Rothlein; T E Hugli; G J del Zoppo; J M Hallenbeck
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

3.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

4.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

5.  Full-length cDNA cloning of Toll-like receptor 4 in dogs and cats.

Authors:  Yuka Asahina; Noriyuki Yoshioka; Rui Kano; Tadaaki Moritomo; Atsuhiko Hasegawa
Journal:  Vet Immunol Immunopathol       Date:  2003-12-15       Impact factor: 2.046

6.  Oxygen distribution in the macaque retina.

Authors:  J Ahmed; R D Braun; R Dunn; R A Linsenmeier
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-03       Impact factor: 4.799

7.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

Review 8.  LPS/TLR4 signal transduction pathway.

Authors:  Yong-Chen Lu; Wen-Chen Yeh; Pamela S Ohashi
Journal:  Cytokine       Date:  2008-03-04       Impact factor: 3.861

9.  ICAM-1/LFA-1 interaction contributes to the induction of endothelial cell-cell separation: implication for enhanced leukocyte diapedesis.

Authors:  Hyun Wee; Hyun-Mee Oh; Jae-Hyeok Jo; Chang-Duk Jun
Journal:  Exp Mol Med       Date:  2009-05-31       Impact factor: 8.718

Review 10.  A comparative review of toll-like receptor 4 expression and functionality in different animal species.

Authors:  Céline Vaure; Yuanqing Liu
Journal:  Front Immunol       Date:  2014-07-10       Impact factor: 7.561

View more
  1 in total

1.  Biochemical and clinical markers of endothelial dysfunction do not outweigh traditional risk factors for the presence of diabetic retinopathy in patients with type 1 diabetes.

Authors:  Alessandra Saldanha de Mattos Matheus; Maria de Fátima Bevilacqua da Matta; Eliete Leão Silva Clemente; Maria de Lourdes Guimarães Rodrigues; Débora Cristina Torres Valença; Karla Rezende Guerra Drummond; Marília Brito Gomes
Journal:  Diabetol Metab Syndr       Date:  2022-09-27       Impact factor: 5.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.